Philip Tsai

Chief Tech/Sci/R&D Officer at IMMUNOME, INC.

Net worth: 2 M $ as of 2026-06-29

58 year

Health Technology

Consumer Services

Profile

Philip Tsai is Chief Technical Officer at Immunome, Inc. since 2024.
Dr. Tsai was Senior Vice President-Technical Development at Seagen, Inc. from 2021 to 2024.
Education includes graduate and doctorate degrees from California Institute of Technology and an undergraduate degree from the University of Illinois At Urbana–Champaign.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IMMUNOME, INC. 0.07%	2026-07-22	81,550 ( 0.07% )	2 M $	2026-06-29

Philip Tsai active positions

Companies	Position	Start
IMMUNOME, INC.	Chief Tech/Sci/R&D Officer	2024-06-26

All active positions of Philip Tsai

Former positions of Philip Tsai

Companies	Position	End
SEAGEN INC.	Chief Tech/Sci/R&D Officer	2024-03-31

See the detail of Philip Tsai's experience

Training of Philip Tsai

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Philip Tsai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Seagen, Inc. Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases	Health Technology
Immunome, Inc. Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics	Health Technology
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Illinois At Urbana–Champaign University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services